VFA
HPTX

Virtus Fund Advisers’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Virtus Fund Advisers’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,161
Closed -$30K – 2652
2014
Q2 		$30K Buy
+1,161
New +$29.8K ﹤0.01% 2210

Other funds holding HPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virtus Fund Advisers's HPTX Position: Q3 2014 in Review

Virtus Fund Advisers sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q3 2014, closing a stake of 1,161 shares — an estimated $30K sold.

Virtus Fund Advisers first reported a position in HPTX in Q2 2014 and held it in 1 quarter. The position peaked at $30K in Q2 2014. 97 funds tracked by Wall St. Rank hold HPTX as of Q3 2014.

  • Virtus Fund Advisers reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,161 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $30K.
  • Virtus Fund Advisers first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $30K in Q2 2014.
  • 97 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.